Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Line 231: | Line 231: | ||
<ol class="carousel-indicators"> | <ol class="carousel-indicators"> | ||
<li data-target="#TBBanner" data-slide-to="0" class="active"></li> | <li data-target="#TBBanner" data-slide-to="0" class="active"></li> | ||
- | <li data-target="#TBBanner" data-slide-to="1 | + | <li data-target="#TBBanner" data-slide-to="1" ></li> |
- | <li data-target="#TBBanner" data-slide-to="2 | + | <li data-target="#TBBanner" data-slide-to="2" ></li> |
</ol> | </ol> | ||
<div class="carousel-inner"> | <div class="carousel-inner"> |
Revision as of 07:56, 26 September 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
Our results here